Lobbying Filing Details

Total Spending

$50,000

Activities

1

Lobbyists

5

Gov't Entities

2

Filing Information
Filing UUID:
a837d495-a0bd-4e02-a19a-84073398d8ab
Type:
Q4 - 4th Quarter - Report
Period:
2013 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 13, 2014 at 9:23 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: James "J.D." Derderian, President
Registrant
STANTON PARK GROUP

government affairs

Annapolis, Maryland
Client
VERTEX PHARMACEUTICALS INCORPORATED

Global biotechnology company

Massachusetts, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Raising awareness of Hepatitis C (no specific bills); Access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); FDA regulatory pathways for pharmaceuticals (no specific bills); H.R. 460 The Patients' Access to Treatments Act of 2013 (all provisions). Awareness of Cystic Fibrosis (no specific bills)

Lobbyists (5)
  • ERIN STRAWN
  • VALERIE HENRY
  • JAMES DERDERIAN
  • PATRICK LYDEN
  • MR. RICHARD MATHER RUSSELL
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.